Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial

Tam, CS (author)

Brown, JR (author)

Kahl, BS (author)

show more...

Ghia, P (author)

Giannopoulos, K (author)

Jurczak, W (author)

Simkovic, M (author)

Shadman, M (author)

Osterborg, A (author)

Karolinska Institutet

Laurenti, L (author)

Walker, P (author)

Opat, S (author)

Chan, HR (author)

Ciepluch, H (author)

Greil, R (author)

Tani, M (author)

Trneny, M (author)

Brander, DM (author)

Flinn, IW (author)

Grosicki, S (author)

Verner, E (author)

Tedeschi, A (author)

Li, JY (author)

Tian, T (author)

Zhou, L (author)

Marimpietri, C (author)

Paik, JC (author)

Cohen, A (author)

Huang, JN (author)

Robak, T (author)

Hillmen, P (author)

show less...

 (creator_code:org_t)

2022

2022

English.

In: The Lancet. Oncology. - 1474-5488. ; 23:8, s. 1031-1043

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)